Valion Bio (VBIO) FCF Margin (2021 - 2025)
Valion Bio (VBIO) posted quarterly FCF Margin of 2906.25% for Q4 2025, down 252736.0% year-over-year from N/an in Q4 2024, and down 111.1% quarter-over-quarter from 1376.71% in Q3 2025.
Valion Bio (VBIO) FCF Margin (2021 - 2025) Analysis & Trends
Valion Bio's FCF Margin history runs 5 years deep, the most recent figure standing at 2906.25% for Q4 2025.
- In Q4 2025, FCF Margin fell 252736.0% year-over-year to 2906.25%; the TTM figure through Dec 2025 stood at 1841.62% (down 119008.0% YoY), while the FY2025 annual figure was 1842.41%, down 119087.0% from the prior year.
- FCF Margin for Q4 2025 stood at 2906.25%, down from 1376.71% in the prior quarter.
- The five-year high for FCF Margin was 202.61% in Q2 2021, with the low at 2906.25% in Q4 2025.
- The 5-year median for FCF Margin is 615.9% (2021), against an average of 882.06%.
- The sharpest annual moves came in 2024 and 2025: FCF Margin surged 65655 bps in 2024, then sank 252736 bps in 2025.
- Valion Bio's FCF Margin stood at 709.51% in 2021, then increased by 23 bps to 543.87% in 2022, then gained by 7 bps to 507.28% in 2023, then climbed by 25 bps to 378.89% in 2024, then tumbled by 667 bps to 2906.25% in 2025.
- Business Quant data shows VBIO's FCF Margin at 2906.25% in Q4 2025, 1376.71% in Q3 2025, and 2093.02% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 22.62% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 41.07% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -22.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 70.82% |
| 10 | Valion Bio | 405,599.63 | -1.79 Mn | -45,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2,906.25% |
| Sep 30, 2025 | -1,376.71% |
| Jun 30, 2025 | -2,093.02% |
| Mar 31, 2025 | -1,285.71% |
| Dec 31, 2024 | -378.89% |
| Sep 30, 2024 | -1,148.41% |
| Jun 30, 2024 | -895.00% |
| Mar 31, 2024 | -508.98% |
| Dec 31, 2023 | -507.28% |
| Sep 30, 2023 | -638.30% |
| Jun 30, 2023 | -1,551.55% |
| Mar 31, 2023 | -670.21% |
| Dec 31, 2022 | -543.87% |
| Sep 30, 2022 | -588.05% |
| Jun 30, 2022 | -321.97% |
| Mar 31, 2022 | -515.42% |
| Dec 31, 2021 | -709.51% |
| Sep 30, 2021 | -593.50% |
| Jun 30, 2021 | -202.61% |
| Mar 31, 2021 | -205.88% |